Burden of disease and risk factors for primary liver cancer by etiology in the United States, 1990-2021: Results from the Global Burden of Disease study, 2021 by Duanyu Wang, Minghao Tan, Socheat Touch, Samnang Kouy, Syphanna Sou, Kun Liu, Youwen Zhu, Hong Zhu, Pengkhun Nov

“…The fastest growing burden of disease was attributed to metabolic dysfunction-associated steatotic liver disease (MASLD)-associated LC. …”
Get full text

The correlation between facial and eyelid demodicosis. Complex therapeutic approaches by D. Yu. Maychuk, M. M. Shokirova, T. A. Simonova, Z. G. Malysheva

Get full text

High-intensity interval training reduces Tau and beta-amyloid accumulation by improving lactate-dependent mitophagy in rats with type 2 diabetes by Pouria Khosravi, Fereshte Shahidi, Arezoo Eskandari, Kayvan Khoramipour

Get full text

Lower Urinary Tract Symptoms in Uterine Myoma: A Systematic Review and Meta-Analysis by Lek-Hong Tan, Li-Hsien Tsai

“…The pooled prevalence for urinary frequency, urgency, nocturia, voiding dysfunction, and overall UI, SUI, UUI, and MUI ranged from 15% to 54%. …”
Get full text

Pentoxyphylline: possibilities to reduce manifestations of chronic heart failure with preserved left ventricular ejection fraction in elderly by V. B. Shatylo, L. A. Bodretska, I. S. Shapovalenko, H. P. Voinarovska, Zh. S. Butynets

Get full text

The impact of liver steatosis on the severity of COVID-19 in patients with chronic coronary syndrome by M.M. Zhaivoronok, S.Ye. Mostovyi, O.M. Safonova

“…It is known that COVID-19 can lead to the reactivation of pre-existing liver conditions, such as metabolic dysfunction-associated steatotic liver disease (MASLD), causing its further progression to liver cirrhosis. …”
Get full text

Assessment of HIV-associated Neurocognitive Disorders in HAART-naïve Individuals: A Cross-sectional Study by Ravi Krishnegowda, Chaitra Rao, Sumesh Yadav, Konda Sai Kiran

Get full text

Study of the state of th vascular endothelium in various forms of coronary heart disease by F. A. Shukurov, M. S. Tabarov, Z. M. Toshtemirova, M. Kh. Khodzhaeva

“…Purpose of the study: to investigate changes in markers of endothelial dysfunction and hemostasis system in patients with different forms of CHD on the background of treatment and before it.Materials and methods of the study. …”
Get full text

Neuroprotective effects and mechanisms of the YiQiWenYangSanHan formula on Parkinson's disease mice by Jinling Liu, Dong Di, Suping Sun, Yan Sun, Shihan Zhou, Jing Liu, Zizhen Qin, Xinyu Yang, Xiao Wang, Zheng Xu, Boran Zhu, Haoxin Wu

“…Aim of this review: This study employed an in vivo model to investigate the effects of YQWYSHF on motor impairments, neuroinflammation, and mitochondrial dysfunction in C57BL/6 J mice caused by MPTP. Materials and methods: Sixty C57BL/6 J mice were randomly divided into 5 groups, all groups except the control group were intraperitoneally administered MPTP for 7 days (30 mg/kg). …”
Get full text

Right heart remodeling in coronary heat disease: clinico-pathophysiological correlations by N. S. Buslenko, Yu. I. Buziashvili, I. V. Koksheneva, E. U. Asymbekova, O. M. Sherstyannikova

“…To study right ventricular (RV) geometry and analyze clinico-pathophysiological processes, associated with right heart remodeling in coronary heart disease (CHD) patients. Material and methods. The study included 184 CHD patients, who underwent dobutamine stress echocardiography (EchoCG). …”
Get full text

Lipid and pleiotropic effects of atorvastatin in patients with acute coronary syndrome by A. A. Yalymov, G G Shekhyan, A. A. Bylyeva, V. S. Zadionchenko

Get full text

Ex vivo lung perfusion in lung transplantation by A. P. Fabrika, E. P. Tychina, A. M. Bayramkulov, E. A. Tarabrin

Get full text

Long-term nifedipine CR therapy and arterial characteristics in hypertensive patients aged over 60 years by V. E. Oleynikov, I. B. Matrosova, E. E. Grishaeva, N. A. Borisova, E. I. Yastrebova

Get full text

Randomized «FARVATER» study. Atorvastatin (10 and 20 mg/d) in treating patients with coronary heart disease and dyslipidemia: effects on lipids, C-reactive protein and fibrinogen l... by A. V. Susekov, M. Yu. Zubareva, M. I. Tripoten’, T. A. Rozhkova, O. A. Pogorelova, T. V. Balakhonova, V. P. Masenko, V. V. Kukharchuk

Get full text

Early Predictors of Severe Acute Pancreatitis by V. V. Kiselev, M. S. Zhigalova, E. V. Klychnikova, P. A. Yartsev

“…BACKGROUND One of the main pathogenetic aspects of the severe course of acute pancreatitis (AP) is endothelial dysfunction. Under normal physiological conditions, the endothelium has both anticoagulant and procoagulant properties. …”
Get full text

The system of anesthesiological support for coloproctological operations by G. A. Myshkov, M. V. Abritsova, N. R. Torchua

Get full text

Three‐dimensional endovaginal ultrasound assessment using the levator ani deficiency score in primiparas: A replication study by Emilia Rotstein, Vilhelmina Ullemar, Marianne Starck, Gunilla Tegerstedt

“…Abstract Introduction It is essential to assess the levator ani properly as part of clinical care in patients presenting with pelvic floor dysfunction. The levator ani deficiency scoring system is a previously published method to assess levator ani defects with three‐dimensional endovaginal ultrasound. …”
Get full text

Stress-induced premature senescence in high five cell cultures: a principal factor in cell-density effects by Rui Min, Dahe Zhang, Mingzhe He, Jingyuan Chen, Xiaoping Yi, Yingping Zhuang

Get full text

WAYS OF PREVENTION SYNDROME OF INTRA-ABDOMINAL HYPERTENSION IN BARIATRIC SURGERY by M. I. Neimark, A. Yu. Elizariev, R. V. Kiselev

Get full text

INFLUENCE OF COMORBIDITIES ON BLOOD ALDOSTERONE LEVEL IN CHRONIC HEART FAILURE WITH PRESERVED SYSTOLIC FUNCTION OF THE LEFT VENTRICLE by N. T. Vatutin, A. N. Shevelyok

“…To analyze relation of blood aldosterone level with comorbidities in patients with chronic heart failure (CHF) with preserved ejection fraction of the left ventricle (EF LV).Material and methods. To the cross-sectional study, 158 patients included: 58 males, 100 females, mean age 62,3±7,4 y. o., with decompensated CHF with preserved EF LV (>50%) and diastolic dysfunction. …”
Get full text